These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 31967007

  • 21. Severe hypocalcaemia following denosumab in a patient with cancer with vitamin D deficiency.
    Watthanasuntorn K, Abid H, Gnanajothy R.
    BMJ Case Rep; 2018 Dec 13; 11(1):. PubMed ID: 30567243
    [Abstract] [Full Text] [Related]

  • 22. Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer.
    Gartrell BA, Coleman RE, Fizazi K, Miller K, Saad F, Sternberg CN, Galsky MD.
    Eur Urol; 2014 Feb 13; 65(2):278-86. PubMed ID: 23706567
    [Abstract] [Full Text] [Related]

  • 23. Severe hypocalcemia after denosumab in a patient with acquired Fanconi syndrome.
    Shafqat H, Alquadan KF, Olszewski AJ.
    Osteoporos Int; 2014 Mar 13; 25(3):1187-90. PubMed ID: 24158473
    [Abstract] [Full Text] [Related]

  • 24. Development of Risk Prediction Model for Grade 2 or Higher Hypocalcemia in Patients With Bone Metastasis Treated With Denosumab Plus Cholecalciferol (Vitamin D3 )/Calcium Supplement.
    Ikegami K, Hashiguchi M, Kizaki H, Yasumuro O, Funakoshi R, Hori S.
    J Clin Pharmacol; 2022 Sep 13; 62(9):1151-1159. PubMed ID: 35383950
    [Abstract] [Full Text] [Related]

  • 25. Severe hypocalcemia following denosumab treatment in a patient with secondary osteoporosis associated with primary sclerosing cholangitis.
    Yasuda Y, Iwama S, Arima H.
    Endocr J; 2019 Mar 28; 66(3):271-275. PubMed ID: 30713246
    [Abstract] [Full Text] [Related]

  • 26. Post-craniopharyngioma surgery hypocalcemia due to denosumab use for osteoporosis: A case report.
    Jia L, Hu Y, Jin G.
    Medicine (Baltimore); 2024 Sep 13; 103(37):e39649. PubMed ID: 39287282
    [Abstract] [Full Text] [Related]

  • 27. Severe hypocalcemia after denosumab treatment leading to refractory ventricular tachycardia and veno-arterial extracorporeal membrane oxygenation support: a case report.
    Okuno F, Ito-Masui A, Hane A, Maeyama K, Ikejiri K, Ishikura K, Yanagisawa M, Dohi K, Suzuki K.
    Int J Emerg Med; 2023 Aug 28; 16(1):52. PubMed ID: 37635211
    [Abstract] [Full Text] [Related]

  • 28. A single-dose study of denosumab in patients with various degrees of renal impairment.
    Block GA, Bone HG, Fang L, Lee E, Padhi D.
    J Bone Miner Res; 2012 Jul 28; 27(7):1471-9. PubMed ID: 22461041
    [Abstract] [Full Text] [Related]

  • 29. Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency.
    Miyaoka D, Imanishi Y, Ohara M, Hayashi N, Nagata Y, Yamada S, Mori K, Emoto M, Inaba M.
    Osteoporos Int; 2019 Jan 28; 30(1):241-249. PubMed ID: 30187112
    [Abstract] [Full Text] [Related]

  • 30. [Pharmaceutical Intervention According to Strict Management System Can Normalize Decreased Serum Calcium Level by Denosumab and Prevent Its Aggravation].
    Saito Y, Uchiyama K, Sakamoto T, Yamazaki K, Kubota K, Takekuma Y, Komatsu Y, Sugawara M.
    Yakugaku Zasshi; 2021 Jan 28; 141(8):1023-1030. PubMed ID: 34334547
    [Abstract] [Full Text] [Related]

  • 31. Denosumab in hypercalcemia of malignancy: a case series.
    Dietzek A, Connelly K, Cotugno M, Bartel S, McDonnell AM.
    J Oncol Pharm Pract; 2015 Apr 28; 21(2):143-7. PubMed ID: 24415364
    [Abstract] [Full Text] [Related]

  • 32. Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion.
    Body JJ, von Moos R, Niepel D, Tombal B.
    BMC Urol; 2018 Sep 20; 18(1):81. PubMed ID: 30236112
    [Abstract] [Full Text] [Related]

  • 33. High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis.
    Ishikawa K, Nagai T, Sakamoto K, Ohara K, Eguro T, Ito H, Toyoshima Y, Kokaze A, Toyone T, Inagaki K.
    Ther Clin Risk Manag; 2016 Sep 20; 12():1831-1840. PubMed ID: 27980413
    [Abstract] [Full Text] [Related]

  • 34. Dose-specific effects of denosumab on serum calcium levels in patients with osteoporosis and various renal functions.
    Sun X, Bolster MB, Leder BZ, Fan W.
    J Clin Endocrinol Metab; 2024 Oct 11. PubMed ID: 39391899
    [Abstract] [Full Text] [Related]

  • 35. Hypocalcemia in Patients With Osteoporosis and Normal Renal Function, Treated With Denosumab, a Retrospective Analysis.
    Bitar ZI, Hajjiah AM, Maadarani OS, Elzoueiry MM, Gohar MR, Abdelfatah M, Alabdali F.
    Nutr Metab Insights; 2024 Oct 11; 17():11786388231223604. PubMed ID: 38205220
    [Abstract] [Full Text] [Related]

  • 36. Diagnosis and Management of Denosumab-Induced Hypocalcemia and Hypophosphatemia in the Setting of Metastatic Prostate Cancer.
    Flood MG, Rowley MA, Basnet A.
    Cureus; 2022 Jan 11; 14(1):e20928. PubMed ID: 35145817
    [Abstract] [Full Text] [Related]

  • 37. Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study.
    Nasser SM, Sahal A, Hamad A, Elazzazy S.
    J Oncol Pharm Pract; 2019 Dec 11; 25(8):1846-1852. PubMed ID: 31694497
    [Abstract] [Full Text] [Related]

  • 38. A Rare Reason for Severe Hypocalcemia Following Kidney Transplant: Denosumab Treatment.
    Aktas M, Oray Unlu HN, Karatas M, Okut G, Eren B, Uslu A, Tatar E.
    Exp Clin Transplant; 2024 Jan 11; 22(Suppl 1):342-344. PubMed ID: 38385423
    [Abstract] [Full Text] [Related]

  • 39. Case report: Denosumab-associated acute heart failure in patients with cardiorenal insufficiency.
    Xing Y, Ju S, Sun M, Xiang S.
    Front Endocrinol (Lausanne); 2022 Jan 11; 13():970571. PubMed ID: 36187135
    [Abstract] [Full Text] [Related]

  • 40. Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.
    Thongprayoon C, Acharya P, Acharya C, Chenbhanich J, Bathini T, Boonpheng B, Sharma K, Wijarnpreecha K, Ungprasert P, Gonzalez Suarez ML, Cheungpasitporn W.
    Osteoporos Int; 2018 Aug 11; 29(8):1737-1745. PubMed ID: 29713798
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.